← Eichor
Study identifier: NCT05887700 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up

Condition: Atrial Septal Defect  ·  Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd.

PhaseN/A
Planned participants145
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

The objective of this post-market registry is to assess the clinical use of the Lifetech CeraFlex™ Closure System in a real-world and on-label fashion.

This description comes directly from the study's public registry record.

Talk to the study team

Rae Gong  ·  (86-755)-86026250-6957  ·  gongrui@lifetechmed.com

Always discuss trial participation with your own doctor first.

Locations (5)

Hospital Pequeno PríncipeCuritiba, BrazilRecruiting
Santa Casa de Misericórdia de Porto AlegrePorto Alegre, BrazilRecruiting
HCOR - Associação Beneficente SíriaSão Paulo, BrazilRecruiting
Hospital Beneficência PortuguesaSão Paulo, BrazilRecruiting
Onassis Cardiac Surgery CenterKallithea, GreeceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05887700